凱立新材(688269.SH):公司未來新增產能主要用於基礎化工領域
格隆匯1月10日丨凱立新材(688269.SH)投資者關係活動記錄表顯示,公司未來新增產能主要用於基礎化工領域。在產能規劃上,公司佈局了一個研發中心和三個生產基地:草灘研發中心落成後會增強公司催化材料與應用技術的研發能力;高陵生產基地主要以精細化工領域用貴金屬催化劑為主;銅川生產基地主要以基礎化工領域用貴金屬催化劑為主;咸陽市彬州生產基地規劃化工新材料、基礎化工和環保新能源等領域用非貴金屬和貴金屬催化劑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.